| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.63M | 37.13M | 46.28M | 42.45M | 29.46M | 12.16M |
| Gross Profit | 24.62M | 23.07M | 26.65M | 23.84M | 16.50M | 5.84M |
| EBITDA | 887.00K | 869.00K | 20.00K | 1.87M | -229.00K | -2.92M |
| Net Income | -975.00K | -544.00K | -423.00K | 1.88M | -142.00K | -2.97M |
Balance Sheet | ||||||
| Total Assets | 28.11M | 28.96M | 23.91M | 27.35M | 17.71M | 7.88M |
| Cash, Cash Equivalents and Short-Term Investments | 7.75M | 7.28M | 8.31M | 10.58M | 7.05M | 3.93M |
| Total Debt | 3.62M | 3.93M | 622.00K | 630.00K | 327.00K | 49.00K |
| Total Liabilities | 11.14M | 11.03M | 5.70M | 8.98M | 7.09M | 2.90M |
| Stockholders Equity | 16.98M | 17.93M | 18.21M | 18.37M | 10.62M | 4.98M |
Cash Flow | ||||||
| Free Cash Flow | 1.75M | -783.00K | -2.09M | -1.91M | -2.33M | -1.32M |
| Operating Cash Flow | 2.90M | 1.82M | -1.55M | -1.51M | -2.28M | -1.27M |
| Investing Cash Flow | -1.57M | -2.60M | -539.00K | -400.00K | -58.00K | -51.00K |
| Financing Cash Flow | -525.00K | -245.00K | -172.00K | 5.44M | 5.46M | -82.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | £35.68M | 4.08 | 4.60% | ― | 17.79% | 18.96% | |
63 Neutral | £476.70M | 11.70 | 7.52% | ― | 13.21% | -54.35% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | £13.96M | -2.99 | -5.59% | ― | -1.65% | -454.55% | |
52 Neutral | £259.19M | -1.12 | -111.93% | ― | -14.89% | 12.08% | |
48 Neutral | £513.61M | 11.73 | -35.25% | ― | -20.36% | 44.33% | |
41 Neutral | £260.43M | -3.32 | -9999.00% | ― | -65.42% | 27.73% |